Kala Pharmaceuticals Stock Faces Uncertainty After Delisting and Liquidation Plan in Biotech Sector
Kala Pharmaceuticals (ISIN: US4831191000) has entered voluntary liquidation, marking the end of its public trading journey on Nasdaq. US investors holding shares must act swiftly as delisting and cash distribution loom, with implications for biotech portfolios amid a challenging funding environment. Here’s what happened, why it matters now, and next steps for shareholders. Kala Pharmaceuticals…

